
Cellectis S.A. CLLS
$ 4.59
-1.92%
Annual report 2024
added 12-13-2025
Cellectis S.A. DSO Ratio 2011-2025 | CLLS
Annual DSO Ratio Cellectis S.A.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | 94.5 | 113 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 113 | 94.5 | 104 |
DSO Ratio of other stocks in the Biotechnology industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Arbutus Biopharma Corporation
ABUS
|
31.5 | $ 4.77 | 1.27 % | $ 792 M | ||
|
Aclaris Therapeutics
ACRS
|
6.01 | $ 3.33 | 2.61 % | $ 257 M | ||
|
Aptorum Group Limited
APM
|
20.6 | $ 1.31 | 0.85 % | $ 7.14 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
84.7 | - | - | $ 40.3 B | ||
|
Ascendis Pharma A/S
ASND
|
132 | $ 218.02 | -1.09 % | $ 5 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.75 K | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
204 | - | -18.52 % | $ 27.3 M | ||
|
Alterity Therapeutics Limited
ATHE
|
16.2 K | $ 3.2 | -2.74 % | $ 7.7 B | ||
|
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
25 | - | -15.15 % | $ 60.3 M | ||
|
Aeglea BioTherapeutics
AGLE
|
216 | - | - | $ 1.01 B | ||
|
Albireo Pharma
ALBO
|
14.7 | - | -0.23 % | $ 916 M | ||
|
Alpine Immune Sciences
ALPN
|
154 | - | - | $ 2.17 B | ||
|
Amphastar Pharmaceuticals
AMPH
|
62.6 | $ 25.93 | 2.61 % | $ 1.26 B | ||
|
Anika Therapeutics
ANIK
|
77.3 | $ 9.58 | 0.21 % | $ 140 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
28.1 | $ 0.28 | -1.82 % | $ 609 M | ||
|
Arena Pharmaceuticals
ARNA
|
946 | - | -6.81 % | $ 3.04 B | ||
|
Catalyst Biosciences
CBIO
|
3.24 | $ 14.27 | 1.28 % | $ 939 M | ||
|
Athersys
ATHX
|
22.6 | - | 3.77 % | $ 22.4 M | ||
|
Axon Enterprise
AXON
|
134 | $ 563.27 | -0.18 % | $ 42.7 B | ||
|
Ayala Pharmaceuticals
AYLA
|
61.7 | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
150 | $ 2.33 | 1.3 % | $ 14.6 M | ||
|
Acorda Therapeutics
ACOR
|
48.3 | - | -24.86 % | $ 820 K | ||
|
Brickell Biotech
BBI
|
254 | - | -5.38 % | $ 6.06 M | ||
|
BeiGene, Ltd.
BGNE
|
49.5 | - | 0.49 % | $ 251 B | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
169 | $ 11.68 | 1.26 % | $ 755 M | ||
|
Biogen
BIIB
|
57.9 | $ 171.54 | -1.47 % | $ 25 B | ||
|
Abeona Therapeutics
ABEO
|
387 | $ 5.34 | -0.37 % | $ 114 M | ||
|
ADiTx Therapeutics
ADTX
|
621 | $ 2.11 | -5.61 % | $ 27.8 K | ||
|
Bellicum Pharmaceuticals
BLCM
|
6.09 | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
103 | - | -7.31 % | $ 87 M | ||
|
Advaxis
ADXS
|
88.1 | - | -9.65 % | $ 45.9 M | ||
|
Фармсинтез
LIFE
|
209 | - | - | - |